Tubeimoside-I

Cat. No. M4262

All AbMole products are for research use only, cannot be used for human consumption.

Synonym:

Tubeimoside-1; Lobatoside-H

Size	Price	Availability
5mg	USD 40 USD40	In stock
10mg	USD 60 USD60	In stock
20mg	USD 80 USD80	In stock

Free Delivery on orders over USD 500 Bulk Inquiry?

Tubeimoside I, an extract of Fritillaria fritillaria, has been proved to be an effective antitumor agent for various human cancers.

Molecular Weight	1319.44
Formula	C63H98O29
CAS Number	102040-03-9
Storage	Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month

Related Apoptosis Products
Coenzyme Q0 Coenzyme Q0 (CoQ0) is a potent, oral active ubiquinone compound. Coenzyme Q0 induces apoptosis and autophagy, suppresses of HER-2/AKT/mTOR signaling to potentiate the apoptosis and autophagy mechanisms. Coenzyme Q0 regulates NFκB/AP-1 activation and enhances Nrf2 stabilization in attenuation of inflammation and redox imbalance.
C6 Ceramide C6 Ceramide (C6-Cer) is a short-chain, cell-permeable ceramide pathway activator with anticancer activity. C6 Ceramide-mediated miR-29b expression participates in the progression of multiple myeloma through suppressing the proliferation, migration and angiogenesis of endothelial cells by targeting Akt signal pathway.
DB2115 tertahydrochloride DB2115 tertahydrochloride is a potent inhibitor of myeloid master regulator PU.1. DB2115 tertahydrochloride has the potential for researching cancers, including hematologic cancers.
14-3-3η Protein inhibitor 1 14-3-3η Protein inhibitor 1 is a 14-3-3η protein inhibitor with a KD of 35 µM.
Deferoxamine Deferoxamine (Deferoxamine B) is an iron chelator (binds to Fe(III) and many other metal cations), is widely used to reduce iron accumulation and deposition in tissues. Deferoxamine upregulates HIF-1α levels with good antioxidant activity. Deferoxamine also shows anti-proliferative activity, can induce apoptosis and autophagy in cancer cells.

Catalog